Cholesterol 2.0™ "Cholesterol Management System" (updated from version 1.1) is the most innovative and up-to-date resource for comprehensive, systematic and NCEP-compliant Blood Cholesterol Management. The program follows exactly the Clinical Guidelines presented in the Third Report of the National Cholesterol Education Program (NCEP) ATP-III (May 2001).

Cholesterol 2.0™ is designed for Physicians (MD) and some other qualified healthcare professionals (RN, PA, NP). The system automates and standardizes personalization, Risk Assessment, Risk Categorization and the generation of Patient-specific Therapeutic recommendations.
The application runs on the browser, is written in Javascript, HTML and MedML™.

Cholesterol 2.0™ incorporates and follows the NCEP Cholesterol Guidelines presented in the ATP-III report. The application automates and standardizes the tasks of CHD Risk Assessment for major risk factors, Framingham Scoring and Metabolic Syndrome. It also automates the generation of Patient-specific Therapeutic recommendations for LDL-lowering therapies, triglyceride, HDL, etc. The program organizes and displays information in the same visual field for easy review and printing. Some of the features include:

individualized Blood Cholesterol Management

color-coded normal/abnormal

automatic CHD Risk Assessment

NCEP-compliant

intuitive interface

Major Risk factors

automatic Framingham Scoring

Patient-specific Therapeutic recommendations

Same visual field formats

organized and standardized

clinical checklists for total quality

hyperlinks to related sections

easy navigation and info access

The Cholesterol Management Tool is ScyMed's new concept. Is a combined reference, productivity and decision-support tool for Blood Cholesterol Management. This integrated resource automates personalization, Risk Assessment and therapeutic recommendations. The tool incorporates two main pages. The input page contains input fields for 22 clinical parameters, Patient data is entered in this page. The output page is the Personal Cholesterol Management Plan. It is displayed in a 2nd browser window, and contains 4 sections (Patient Data, Risk assessment, Risk category and Therapeutic recommendations). The output page may be printed-to-chart. Changes to inputs can be readily done. The output page is quickly and automatically re-computed to display the new data and recommendations.

Learn more about the Cholesterol Mangement Tool in the tutorial section.

The Coronary Heart Disease (CHD) Risk Assessment Tool automates the task of Risk assessment. The tool generates Patient-specific CHD-Risk assessments for Major Risk Factors and Framingham Point Scores. This tool also incorporates two main pages. The input page contains input fields for 13 clinical parameters. The output page displays the Patient CHD Risk Assessment in a 2nd browser window. The system permits quick and repeated Risk assessments under different scenarios and risk factors.

Learn more about the CHD Risk Assessment Tool in the tutorial section.

The Color-coded feature displays abnormal values, out-of-range values and positive risk factors in red color. This is true for both, the Cholesterol tool and the CHD Risk tool.

This innovative feature allows quick and efficient identification of abnormal or positive data.

The NCEP Cholesterol Guidelines are those presented in the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Executive Summary.
These Guidelines are published by:

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
National Heart, Lung, and Blood Institute
NIH Publication No. 01-3670 (May 2001)

The ScyMed's Cholesterol 2.0™ software program follows the NCEP Cholesterol Guidelines, it is developed and marketed independently by ScyMed, a private medical software company, in the US and other countries. ScyMed is in no way related to the NCEP/NIH/NHLBI. This application is not endorsed/approved in any way by the NCEP/NIH/NHLBI.
ScyMed's Cholesterol 2.0™ is not developed for any single pharmaceutical company.

"What If" analysis is hypothetical analysis, the advent of computers and software systems have allowed what-if analysis in other disciplines for years. Cholesterol 2.0™ enables Physicians to perform "What If" analysis of actual clinical scenarios of real life patients on a routine basis with ease and reliability.

Cholesterol 2.0™ is not a diagnostic program, it is a decision-support, reference and productivity tool. Cholesterol 2.0™ algorithms and contents are based on the NCEP Cholesterol Guidelines. The application automates the tasks and processing.
Cholesterol 2.0™ saves time, increases accuracy and supports medical decision making. It also helps and facilitates clinical information organization and management by offering Physicians a standard, consistent approach to blood cholesterol management. It helps putting the guidelines into practice.

ScyMed's Cholesterol 2.0™ combines leading technologies such as object-oriented programming and the open standards of the Internet, see system requirements.
It is a browser-based application, what means that it runs on a www browser (Explorer) and that it is Internet, Intranet and PC-ready. The System is flexible, versatile and scalable. Learn more about it under features.

No. ScyMed's Cholesterol 2.0 is only available online at our website (www.scymed.com). It is part of the ScyMed Network (including MediCalculator™ and eH&P™). It is only available by subscription (paid).
The program is optimized to run on the internet (Hospital intranets and private networks) but is essentially the same. The online system can be accessed from anywhere in the world, anytime, "n" times. Visit ScyMed to learn more.